Group One Trading’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$766 Buy
+547
New +$766 ﹤0.01% 1859
2025
Q1
Hold
0
2064
2024
Q4
Hold
0
2135
2024
Q3
Hold
0
1805
2024
Q2
Sell
-22,559
Closed -$177K 1829
2024
Q1
$177K Buy
22,559
+17,519
+348% +$137K ﹤0.01% 687
2023
Q4
$25.6K Buy
+5,040
New +$25.6K ﹤0.01% 1215
2023
Q3
Sell
-15,413
Closed -$114K 2002
2023
Q2
$114K Sell
15,413
-24,256
-61% -$180K ﹤0.01% 825
2023
Q1
$375K Buy
39,669
+37,657
+1,872% +$356K ﹤0.01% 518
2022
Q4
$21.4K Sell
2,012
-70,244
-97% -$748K ﹤0.01% 1295
2022
Q3
$533K Buy
72,256
+27,785
+62% +$205K ﹤0.01% 537
2022
Q2
$214K Buy
44,471
+31,864
+253% +$153K ﹤0.01% 848
2022
Q1
$64K Buy
12,607
+11,544
+1,086% +$58.6K ﹤0.01% 1366
2021
Q4
$6K Buy
+1,063
New +$6K ﹤0.01% 1947
2021
Q3
Hold
0
2122
2021
Q2
Sell
-4,385
Closed -$33K 2046
2021
Q1
$33K Sell
4,385
-27,879
-86% -$210K ﹤0.01% 1459
2020
Q4
$252K Buy
32,264
+29,553
+1,090% +$231K ﹤0.01% 806
2020
Q3
$26K Buy
+2,711
New +$26K ﹤0.01% 1187
2017
Q3
Sell
-602
Closed -$22K 1321
2017
Q2
$22K Hold
602
﹤0.01% 1016
2017
Q1
$27K Buy
602
+167
+38% +$7.49K ﹤0.01% 953
2016
Q4
$11K Hold
435
﹤0.01% 1073
2016
Q3
$18K Buy
435
+333
+326% +$13.8K ﹤0.01% 923
2016
Q2
$5K Buy
102
+70
+219% +$3.43K ﹤0.01% 1049
2016
Q1
$2K Sell
32
-243
-88% -$15.2K ﹤0.01% 1112
2015
Q4
$27K Sell
275
-51
-16% -$5.01K ﹤0.01% 990
2015
Q3
$17K Buy
326
+209
+179% +$10.9K ﹤0.01% 1131
2015
Q2
$9K Buy
117
+30
+34% +$2.31K ﹤0.01% 1195
2015
Q1
$6K Sell
87
-63
-42% -$4.35K ﹤0.01% 1145
2014
Q4
$27K Buy
+150
New +$27K ﹤0.01% 1021